News archives 2018.10

Home > 2018.10

2018.10.23

NBHL will attend BIO-Europe 2018 in Copenhagen, Denmark.

NBHL will be at “BIO-Europe 2018” to be held in Copenhagen, Denmark, from November 5th to 7th, 2018. Kiyoshi Takayama (CEO, NBHL) will attend this exciting event and would like to meet you there.

 

For more information on this event, please visit https://ebdgroup.knect365.com/bioeurope/

2018.10.16

NBHL to present at the HUMAN ANTIBODIES & HYBRIDOMAS 2018 Conference in Riga, Latvia

Kiyoshi Takayama (CEO, NBHL) will give a presentation at the HUMAN ANTIBODIES & HYBRIDOMAS 2018 Conference to be held in Riga, Latvia, from October 22nd to 24th, 2018.

[Date of presentation]

October 23rd, 2018

[Venue]

Pullman Riga Old Town Hotel, Riga, Latvia

[Session]

Session 5: Therapeutic targets and antibody immunotherapy

[Presentation title]

MoGRAA® discovery engine can expand the drug targets of therapeutic mAb

[URL]

http://www.meetingsmanagement.co.uk

2018.10.07

NBHL will be present at BioJapan 2018 in Yokohama, Japan

NBHL will have a panel exhibition at B-02 (in Hokkaido BIO Technology Cluster booth) in “BioJapan 2018” to be held in Pacifico Yokohama, Japan, from October 10th to 12th, 2018. Kiyoshi Takayama (CEO, NBHL) will make a short presentation on “MoGRAA® discovery engine”, our technology platform for the discovery of functional monoclonal antibody therapeutics targeting GPCRs. This presentation is scheduled at Stage B of Exhibitor’s Presentation from 14:00 to 14:10 on October 10th.

For more information on this event, please visit https://www.ics-expo.jp/biojapan/en/